Markets & Regulations

India launches 'similar biologics' guidelines at BIO2012

India launches 'similar biologics' guidelines at BIO2012

By Gareth Macdonald

New 'similar biologics' guidelines will curb the rising cost of innovation, attract overseas investment and ensure patients have access to drugs according to the Indian Government team which launched them at BIO 2012.

Follow us

Products

View more

Webinars